Tag Archives: venture capital

Putting the M Back in M&A

Joe Panetta, president and CEO of BIOCOM, discusses an emerging model of M&As in which human and IP assets are valued and biotech brings expertise to Big Pharma as venture capitalist funding dwindles and patent cliffs loom large. Pharm Exec: Can you tell me about how small biotech and specialty companies have started switching from […]
Posted in Agency Insight, Biotech, Deals, FDA | Also tagged , , | Leave a comment

BIO Convention: Potemkin Pavilions and the Power of NICE

Image by Getty Images via Daylife Last week’s annual meeting of BIO in Chicago once again proved illustrative in showcasing the high profile that governments now plays as the biotech sector’s chief advocate. While private venture capitalists confined themselves to the margins of the meeting, the Convention hall was bursting at the seams with host […]
Posted in Biotech | Also tagged , , , , , , | Leave a comment

Upcoming Webcast: Data Driven Laboratory Asset Management Programs

Unlock unknown capital and drive efficiency while improving quality and scientist experience Wednesday, June 17, 2009 at 10 AM EST With increasing pressure in the pharmaceutical and biotech industry to reduce the costs of developing new drugs, more companies are looking at consolidating suppliers and partnering with global providers to enable them gain economies of […]
Posted in Webcast | Also tagged , , , , , , | Leave a comment

Conversation with Eisai’s Lonnel Coats

“The phones are ringing,” said Lonnel Coats, president of Eisai and a plenary speaker here at HBA’s Leadership Conference. “There’s a lot more opportunity, but also a lot more white noise.” Coats is referring to the pressure that cash-strapped biotechs are feeling to sell out and says he gets no less than five calls a […]
Posted in Events, Strategy | Also tagged , , , , | Leave a comment
  • Categories

  • Meta